About CPL Biologicals
CPL Biologicals is a Healthcare company based in Ahmedabad (India) founded in 2009. It develops high-quality vaccines, biologics, and diagnostics using advanced biological technologies. It operates on a B2B model. The company has 24 employees. Its Indian entity Cpl Biologicals Private Limited reported revenue of ₹8.01 Cr. CPL Biologicals offers products and services including Cadiflu S, Vaccines, Biologics, and Diagnostic. Its focus areas include Health and Biotechnology, Biologics, Diagnostic Solutions and Recombinant Technology.
Company details
CPL Biologicals is a biotechnology company focused on creating affordable vaccines, biologics, and diagnostics to address global health challenges. It utilizes technologies like Virus Like Particle and Recombinant Nanoparticle for research and manufacturing. The company operates from facilities in Ahmedabad and Dholka in India, and Gaithersburg in the USA, emphasizing efficient production and safety. It aims to provide solutions for healthcare needs through state-of-the-art RD and compliance with global standards.
- Headquarters Ahmedabad, India
- Employees 24
- SectorsHealthcare
- Email••••••••
- Website cplbio.com
- Legal Name Cpl Biologicals Private Limited
- Date of Incorporation 24 Mar, 2009
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹8.01 Cr
FY 2025 · -6% YoY
- Net Profit₹72.6 Lakh
FY 2025 · 9% margin
- EBITDA₹2.19 Cr
FY 2025 · 27% margin
- Employee Count24
Associated legal entities of CPL Biologicals
CPL Biologicals operates through Cpl Biologicals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cpl Biologicals Private Limited CIN U01403GJ2009PTC056409 | Active | 24 Mar 2009 | Ahmedabad, Gujarat | ₹8.0 Cr | 24 | 7 | View details |
Products & Services of CPL Biologicals
CPL Biologicals offers a comprehensive portfolio of products and services, including Cadiflu S, Vaccines, Biologics, and Diagnostic.
Seasonal influenza vaccine using Virus Like Particle technology for immune response.
Products for preventing diseases through biological systems.
Substances derived from living organisms for medical applications.
Tools for detecting health conditions using advanced assays.
Board of directors of Cpl Biologicals Private Limited (CPL Biologicals)
Cpl Biologicals Private Limited is the primary company behind CPL Biologicals. The board of Cpl Biologicals Private Limited currently have 4 directors; the longest-serving is Rajiv Indravadan Modi, appointed in 2009. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajiv Indravadan Modi DIN 01394558 | Director | 24 Mar 2009 | 17 yrs 7 mo | Cpl Biologicals Private Limited |
| Ramesh Ratilal Choksi DIN 06636737 | Director | 03 Nov 2018 | 7 yrs 11 mo | Cpl Biologicals Private Limited |
| Rajiv Rajiv Modi DIN 10276899 | Director | 04 Jul 2024 | 2 yrs 3 mo | Cpl Biologicals Private Limited |
| Amitabha Banerjee DIN 05152456 | Director | 19 Dec 2024 | 1 yr 10 mo | Cpl Biologicals Private Limited |
Financials of CPL Biologicals
Figures of Cpl Biologicals Private Limited, the primary company behind CPL Biologicals, for FY 2025. Revenue was ₹8.01 Cr (-6% year on year). Net profit was ₹72.6 Lakh (9% margin). EBITDA was ₹2.19 Cr (27% margin). Revenue has grown at a compounded annual rate of -15% over three years and -13% over five years.
- ₹8.01 CrRevenue · FY 2025 · -6% YoY
- ₹72.6 LakhNet profit · 9% margin
- ₹2.19 CrEBITDA · 27% margin
- ₹45.27 CrPaid-up capital
- 24Employees (provident fund records)
- -15%Revenue CAGR, 3 years
- -13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cpl Biologicals Private Limited are on its company page.
Detailed financial statements for CPL Biologicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CPL Biologicals
CPL Biologicals was founded in 2009.
CPL Biologicals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
CPL Biologicals has 24 employees.
The primary company behind CPL Biologicals, Cpl Biologicals Private Limited, reported revenue of ₹8.01 Cr for FY 2025, down 6% year on year.
CPL Biologicals is a biotechnology company focused on creating affordable vaccines, biologics, and diagnostics to address global health challenges. It utilizes technologies like Virus Like Particle and Recombinant Nanoparticle for research and manufacturing. The company operates from facilities in Ahmedabad and Dholka in India, and Gaithersburg in the USA, emphasizing efficient production and safety. It aims to provide solutions for healthcare needs through state-of-the-art RD and compliance with global standards.
CPL Biologicals offers Cadiflu S, Vaccines, Biologics, and Diagnostic.
CPL Biologicals operates through Cpl Biologicals Private Limited.
The legal entities of CPL Biologicals currently have 7 directors, including Ramesh Ratilal Choksi, Rajiv Indravadan Modi, Amitabha Banerjee and others.